Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Effect of Aspirin on Renal Disease Progression in Patients With Type 2 Diabetes: a Multicentre Double-blind, Placebo-controlled, Randomised Trial. The LEDA (renaL disEase Progression by Aspirin in Diabetic pAtients) Study.

NCT02895113 is registered in ClinicalTrials.gov with University of Roma La Sapienza as lead sponsor.

NCT NCT02895113
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT02895113 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Effect of Aspirin on Renal Disease Progression in Patients With Type 2 Diabetes: a Multicentre Double-blind, Placebo-controlled, Randomised Trial. The LEDA (renaL disEase Progression by Aspirin in Diabetic pAtients) Study.
Lead sponsor
University of Roma La Sapienza
Phase
Phase 3
Overall status
Unknown status
Start date
January 31, 2017
Completion date
September 30, 2018
Enrollment
418 (estimated)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

diabetes